Medium materiality6/10
Jefferies raises Disc Medicine price target to $149
Why it may matterVerify against the original reporting
Strongly bullish analyst signal based on the large target gap; the target remains an opinion, not a forecast guarantee.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies raised its target for Disc Medicine to $149, about 96% above the posted price of $76.
- Target raised to $149; about 96% above the $76 posted price.
Key facts
- 01
Target: $149
- 02
Posted price: $76
- 03
Analyst firm: Jefferies
- 04
Analyst: Roger Song
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.